Moreover, chronic inflammation and tissue injury, as observed in various gastrointestinal and hepatic disorders, maintain persistent IL-6/STAT3 activation that supports the proliferation of mutated epithelial cells and contributes to tumor initiation and progression (He and Karin, 2011). Here, IL6 is linked to liver disorder.